文献速递脑血管病神经重症与神经感染

人自发性脑出血中的固有免疫抗炎反应

Innate Immune Anti-Inflammatory Response in Human Spontaneous Intracerebral Hemorrhage.
PubMed 文献 · Stroke · 2021-07-20

该研究通过免疫组化分析27例自发性脑出血(sICH)后1–12天脑组织及26例前瞻性患者循环炎症标志物,发现抗炎标志物CD163和CD206与促炎标志物同时升高,CD163在7–12天升高15.0倍,CD206在3–5天升高5.2倍,表明sICH后存在平行于神经炎症的抗炎修复通路,为治疗提供新靶点及3–5天时间窗。

要点

  • sICH后脑内抗炎标志物CD163和CD206与促炎标志物同时升高。
  • CD163在7–12天升高15.0倍,CD206在3–5天升高5.2倍后回落。
  • 循环CRP和单核细胞在3–5天升高,7–12天下降,单核细胞或可递送治疗。

核心结论

  • sICH后存在由固有微胶质细胞和血单核细胞参与的抗炎通路,与神经炎症并行。
  • 该通路提供治疗靶点及sICH后3–5天递送治疗的时间窗。

研究设计与样本

  • 对27例幕上sICH患者死后1–12天脑组织及匹配对照进行免疫组化标志物定量分析。
  • 另前瞻性纳入26例sICH患者,检测1–12天循环CRP、白细胞总数和单核细胞计数。

主要发现

  • 27例sICH脑组织中所有微胶质-巨噬细胞标志物较对照脑组织升高。
  • 抗炎标志物CD163和CD206与促炎标志物CD68和TMEM119同时升高。
  • CD163在7–12天升高15.0倍(P<0.001),CD206在3–5天升高5.2倍(P<0.001)后于7–12天回落至对照水平。
  • 脑实质免疫反应兼有脑源性微胶质细胞(TMEM119阳性)和浸润单核细胞源性巨噬细胞(CD206阳性)。
  • 前瞻性队列中血CRP从0–2天至3–5天升高8.3倍(P=0.020)后于7–12天下降,单核细胞升高1.8倍(P<0.001)后下降,白细胞未升高。

关键数值与推荐

  • CD163在sICH后7–12天较对照升高15.0倍(P<0.001)。
  • CD206在sICH后3–5天较对照升高5.2倍(P<0.001),7–12天回落至对照水平。
  • 血CRP从0–2天至3–5天升高8.3倍(P=0.020),7–12天下降。
  • 血单核细胞从0–2天至3–5天升高1.8倍(P<0.001),7–12天下降。

临床怎么用

  • sICH后3–5天为抗炎修复通路活跃窗口,或可借此时间窗经浸润单核细胞递送治疗。
  • CD163和CD206等抗炎标志物可作为评估sICH后免疫修复过程的潜在指标。

局限性

  • 脑组织分析样本量较小(27例),且为死后组织,不能完全反映动态过程。
  • 前瞻性循环标志物队列样本量较小(26例),未报告全部基线特征。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Spontaneous intracerebral hemorrhage (sICH) is a common form of hemorrhagic stroke, with high mortality and morbidity. Pathophysiological mechanisms in sICH are poorly understood and treatments limited. Neuroinflammation driven by microglial-macrophage activation contributes to brain damage post-sICH. We aim to test the hypothesis that an anti-inflammatory (repair) process occurs in parallel with neuroinflammation in clinical sICH. METHODS: We performed quantitative analysis of immunohistochemical markers for microglia and macrophages (Iba1, CD68, TMEM119, CD163, and CD206) in brain tissue biospecimens 1 to 12 days post-sICH and matched control cases. In a parallel, prospective group of patients, we assayed circulating inflammatory markers (CRP [C-reactive protein], total white cell, and monocyte count) over 1 to 12 days following sICH. RESULTS: In 27 supratentorial sICH cases (n=27, median [interquartile range] age: 59 [52–80.5], 14F/13M) all microglia-macrophage markers increased post-sICH, relative to control brains. Anti-inflammatory markers (CD163 and CD206) were elevated alongside proinflammatory markers (CD68 and TMEM119). CD163 increased progressively post-sICH (15.0-fold increase at 7–12 days, P<0.001). CD206 increased at 3 to 5 days (5.2-fold, P<0.001) then returned to control levels at 7 to 12 days. The parenchymal immune response combined brain-derived microglia (TMEM119 positive) and invading monocyte-derived macrophages (CD206 positive). In a prospective sICH patient cohort (n=26, age 74 [66–79], National Institutes of Health Stroke Scale on admission: 8 [4–17]; 14F/12M) blood CRP concentration and monocyte density (but not white blood cell) increased post-sICH. CRP increased from 0 to 2 to 3 to 5 days (8.3-fold, P=0.020) then declined at 7 to 12 days. Monocytes increased from 0 to 2 to 3 to 5 days (1.8-fold, P<0.001) then declined at 7 to 12 days. CONCLUSIONS: An anti-inflammatory pathway, enlisting native microglia and blood monocytes, occurs alongside neuroinflammation post-sICH. This novel pathway offers therapeutic targets and a window of opportunity (3–5 days post-sICH) for delivery of therapeutics via invading monocytes.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Shtaya A, Bridges LR, Williams R, et al. Innate Immune Anti-Inflammatory Response in Human Spontaneous Intracerebral Hemorrhage. Stroke. 2021. PMID: 34281379. doi:10.1161/STROKEAHA.121.034673

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。